Latest Breaking News On - Simonettai gaumond - Page 1 : comparemela.com

Study shows GHRH antagonist s role in AML drug resistance

A new research paper was published in Oncotarget's Volume 15 on April 8, 2024, entitled, "Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia."

United statesUniversity of miamiFlorida atlantic universityRama abdinJoaquinj jimenezSimonettai gaumondJoel costoyaAndrewv schallyVeterans affairs medical centerAcute myeloid leukemiaMyeloid leukemiaBone marrowGrowth hormone

Research: MIA-602 May Overcome Doxorubicin-Resistance in AML

Research: MIA-602 May Overcome Doxorubicin-Resistance in AML
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesFlorida atlantic universityUniversity of miamiRama abdinJoel costoyaJoaquinj jimenezSimonettai gaumondAndrewv schallyVeterans affairs medical centerOncotarget volume

Exploring the role of MIA-602 in overcoming doxorubicin-resistance in acute myeloid leukemia

Exploring the role of MIA-602 in overcoming doxorubicin-resistance in acute myeloid leukemia
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesFlorida atlantic universityUniversity of miamiAndrewv schallyJoel costoyaJoaquinj jimenezSimonettai gaumondRama abdinVeterans affairs medical center